Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

(2011) J. Stebbing et al.   ANNALS OF ONCOLOGY

High-density lipoprotein cholesterol and apolipoprotein A1 levels strongly influence the reactivity of small peripheral arteries

(2011) Raimon Ferré et al.   ATHEROSCLEROSIS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Adjuvant Taxanes: More to the Story

(2010) Devika Gajria et al.   Clinical Breast Cancer

The metabolic syndrome in cancer survivors

(2010) Esther C de Haas et al.   LANCET ONCOLOGY

Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?

(2010) Catherine M. Kelly et al.   Surgical Oncology Clinics of North America

Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy

(2009) H. C. Keun et al.   CLINICAL CANCER RESEARCH

Body weight change in women receiving adjuvant chemotherapy for breast cancer: A French prospective study

(2009) Olivier Trédan et al.   CLINICAL NUTRITION

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

(2008) N S Majhail et al.   BONE MARROW TRANSPLANTATION